Kanetada Shimizu

USPTO Granted Patents = 14 (Patent Applications = 4)

CIPO Patents = 6 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 8)

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 7(Granted Patents)

Location History:

Zama, JP (2012 - 2022)
Kanagawa, JP (2016 - 2022)

Company Filing History:

13 out of 185

Morinaga Milk Industry Co., Ltd.

Years Active: 2012-2024

where 'Filed Patents' based on already Granted Patents

14 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12090181 - Bifidobacterium genus bacterium (2024-09-17),

2. 11504407 - genus bacterium (2022-11-22),

3. 11400122 - Composition for alleviating mental health disorder (2022-08-02),

4. 11241463 - Lactic acid bacterium, drug, food or drink, and feed which contain the lactic acid bacterium (2022-02-08),

5. 10980849 - Brain function improving agent (2021-04-20),

6. 10653730 - Lactic acid bacterium, drug, food or drink, and feed which contain the lactic acid bacterium (2020-05-19),

7. 10335441 - Oral composition containing bifidobacteria and cruciferous vegetable (2019-07-02),

8. 10064903 - Lactic acid bacterium, drug, food or drink, and feed which contain the lactic acid bacterium (2018-09-04),

9. 9345743 - Agent for promoting proliferation of bifidobacteria (2016-05-24),

10. 9060529 - Method for treatment of lacto-N-biose-containing solution (2015-06-23),

11. 8497114 - Anti-obesity agent, anti-obesity food or beverage, glucose tolerance-ameliorating agent, and food or beverage for amelioration of glucose tolerance (2013-07-30),

12. 8338161 - Lactic acid bacteria (2012-12-25),

13. 8277857 - Method for producing fermented milk (2012-10-02),

14. 8277856 - Method of producing acidic lactic acid bacteria beverage (2012-10-02),

Title: Inventor Profile: Kanetada Shimizu

Introduction

Kanetada Shimizu is an esteemed inventor based in Zama, Japan, known for his significant contributions to the field of microbiology and biochemistry. With a total of 14 patents to his name, Shimizu's work focuses on innovative bacterium applications that have the potential to impact various industries positively.

Latest Patents

Among his recent inventions, Shimizu has developed novel bacteria with opioid peptide decomposition action and noncollagenous glycoprotein decomposition capabilities. These inventions are defined by unique microorganisms, including MCC1092 (NITE BP-02429), MCC1319 (NITE BP-02431), MCC1868 (NITE BP-02432), MCC1870 (NITE BP-02433), and subsp. MCC1110 (NITE BP-02430). He has also introduced compositions that utilize these bacteria as active ingredients for decomposing opioid peptides and noncollagenous glycoproteins, showcasing his groundbreaking approach to biotechnology.

Career Highlights

Shimizu has worked with notable companies, including Morinaga Milk Industry Co., Ltd. and Sunstar Inc., where he has conducted pivotal research and development in microbiological applications. His innovative work continues to pave the way for advancements in food technology and medical science.

Collaborations

Throughout his career, Kanetada Shimizu has collaborated with distinguished researchers such as Toshitaka Odamaki and Tomohiro Tanaka. These partnerships have fostered a dynamic exchange of ideas and helped propel his inventions to the forefront of scientific research.

Conclusion

Kanetada Shimizu is a prolific inventor whose dedication to microbiological innovation is evident in his numerous patents and industry collaborations. His work not only contributes to scientific progress but also opens up new avenues for applications within health and nutrition sectors.

This text is generated by artificial intelligence and may not be accurate.